Adam Resnick2

publication date: Mar. 8, 2019

Conversation with The Cancer Letter CHOP’s Resnick: Big data will transition from research to the standard of care in the clinic

Adam Resnick

Director, Center for Data Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia; Scientific chair, Children’s Brain Tumor Tissue Consortium and Pacific Pediatric Neuro-Oncology Consortium

 

 

Matthew Ong:

Is there a need for a consolidated data commons for pediatric cancer? What are you hearing from the childhood cancer community?

Adam Resnick:

I think this would be a universal answer in the pediatric cancer community: the data needs are not currently met, and it’s for a variety of different reasons that are distinguished in the pediatric setting, compared to the adult cancer landscape.

Centralization is one approach, especially as supported by disease-specific efforts or NIH entities, but there is also a likely need for federation across a decentralized data commons landscape.

 

MO:

Can you describe what you’ve learned in your work on data-driven discovery, and how that approach could inform the creation of a larger, federated model for databases?

AR:

One … Continue reading CHOP’s Resnick: Big data will transition from research to the standard of care in the clinic

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you’re not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

(Excerpt) Read more Here | 2019-03-08 22:36:21
Image credit: source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.